Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Renovaro Biosciences (DE:2Q5)
FRANKFURT:2Q5
RESEARCH TOOLSreports
Holding DE:2Q5?
Track your performance easily
| Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | $ 61.22K | $ 246.08K |
| Gross Profit | - | - | - | $ 61.22K | $ 246.08K |
| EBIT | $ -73.52M | $ -17.19M | $ -4.25M | $ -9.00M | $ -22.94M |
| EBITDA | $ -73.40M | $ -17.19M | $ -4.22M | $ -8.81M | $ -22.79M |
| Net Income Common Stockholders | $ -49.92M | $ -17.02M | $ -4.53M | $ -9.18M | $ -23.20M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 220.47K | $ 312.70K | $ 243.98K | $ 523.47K | $ 1.87M |
| Total Assets | $ 163.13M | $ 212.28M | $ 58.02M | $ 57.56M | $ 58.30M |
| Total Debt | $ 3.79M | $ 8.57M | $ 7.39M | $ 4.60M | $ 5.59M |
| Net Debt | $ 3.57M | $ 8.26M | $ 7.15M | $ 4.07M | $ 3.72M |
| Total Liabilities | $ 31.15M | $ 43.68M | $ 14.42M | $ 10.82M | $ 11.80M |
| Stockholders Equity | $ 131.98M | $ 168.60M | $ 43.60M | $ 46.75M | $ 46.50M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -2.44M | - | $ -3.19M | $ -2.78M | $ -2.27M |
| Operating Cash Flow | $ -2.41M | $ -2.63M | $ -3.15M | $ -2.78M | $ -2.26M |
| Investing Cash Flow | $ -53.37K | $ -91.60K | $ -57.33K | $ -1.06M | $ -6.14K |
| Financing Cash Flow | $ 2.47M | $ 2.64M | $ 2.85M | $ 2.56M | $ 1.25M |